SCHEMBL18976466

SCHEMBL18976466

Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)Nc1ccc2oc(C(=O)N3CCSCC3)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRAS P01112 4/20 0.41
▸ ESR1 P03372 4/20 0.41
▸ ESR2 Q92731 4/20 0.41
▸ HRH4 Q9H3N8 2/20 0.41
▸ SYK P43405 1/20 0.38
▸ PRKDC P78527 1/20 0.37
▸ RAB9A P51151 5/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ STAT3 P40763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18976462 0.92 NPC1 (0.45) HRASESR1ESR2HRH4SYK
SCHEMBL18976206 0.91 RAB9A (0.46) HRASESR1ESR2HRH4SYK
SCHEMBL20581440 0.88 HRH4 (0.44) HRASESR1ESR2HRH4SYK
SCHEMBL18954276 0.86 HRAS (0.40) HRASESR1ESR2HRH4SYK
SCHEMBL18976140 0.85 HRH4 (0.38) HRH4SYKPRKDCRAB9AALDH1A1
SCHEMBL18976174 0.85 HRAS (0.39) HRASESR1ESR2HRH4SYK
SCHEMBL18976464 0.84 HRAS (0.37) HRASESR1ESR2PRKDCRAB9A
SCHEMBL18976175 0.84 HRAS (0.45) HRASESR1ESR2PRKDCRAB9A
SCHEMBL18976489 0.84 AR (0.41) HRASESR1ESR2PRKDCALDH1A1
SCHEMBL18976463 0.83 HRAS (0.45) HRASESR1ESR2SYKPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed
WO-2017098257-A1 PBD ANTIBACTERIAL AGENTS KING'S COLLEGE LONDON (GB) 2017-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS HRAS 3085/4885ESR1 2406/4885ESR2 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback